Evaluation of the Long-term Safety and Efficacy of a Tacrolimus-based 5-day Steroid Rapid Withdrawal Immunoprophylactic Regimen in de Novo Renal Transplantation
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Tacrolimus (Primary) ; Mycophenolate mofetil; Prednisone
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma; Astellas Pharma Canada
- 24 Mar 2009 Planned end date added (Mar 2007) as reported by ClinicalTrials.gov.
- 12 Jan 2007 Status change
- 30 Nov 2005 New trial record.